Key Benefit 
Pharmacor, Decision Resources' flagship advisory service, analyzes and forecasts the commercial outlook for drugs in research and development.

Moreover, Decision Resources' analysts are available to speak one-on-one with members of your organization to answer content-related questions on each report.
 

 

 

Analyzing and Forecasting the Commercial Outlook for Drugs on the Market and in Research and Development

Pharmacor, Decision Resources' flagship advisory service, analyzes and forecasts the commercial outlook for currently marketed drugs and drugs in research and development. The medical and technical judgments contained in Pharmacor services are developed from in-depth interviews with thought leading physicians and researchers in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan— the major pharmaceutical markets.

Pharmacor comprises eight individual therapeutic area programs:

• Cardium: cardiovascular diseases such as congestive heart failure and hypertension
• Cognos: neurological and psychiatric disorders such as Alzheimer's disease, Parkinson's disease, and major depression
• Immune & Inflammatory Diseases: immune system disorders such as asthma and rheumatoid arthritis
• Infectious Disease: infectious diseases such as HIV and hepatitis C
• Onkos: cancers such as breast cancer and multiple myeloma
• Metabolic Disorders: indications such as type 2 diabetes and dyslipidemia
• Mosaic: high-interest disease states such as erectile dysfunction and urinary incontinence
• Pain Management: therapeutic approaches associated with pain management

Each Pharmacor report comes with the Interactive Forecast Tool, a Microsoft Excel spreadsheet used to build a seven-country market forecast based on Decision Resources' patient-based market models. The Interactive Forecast Tool can also accommodate a combination of individual drugs or drug classes, with clients having the option to add as many as ten additional entries for interactive, custom market forecasts. This application permits detailed "what-if" analyses of Decision Resources' patient-based five- and ten-year forecasts.

Decision Resources supports collaborative efforts in the field of medicine and pharma market research by allowing for a two-way flow of information and professional advice. A significant benefit to organizations subscribing to Pharmacor is access to the analysts who authored the purchased report. The analysts are available to speak one-on-one with members of your organization to answer content-related questions.

The sections in each Pharmacor report include:

• Epidemiology
• Etiology and Pathophysiology
• Current Therapies
• Medical Practice
• Unmet Clinical Need
• Emerging Therapies
• Market Outlook

Interactive Forecast Tool

Allows you to take your assumptions and interact with Decision Resources’ patient-based 5- and 10-year forecasts.